May 2012
The Medicines and Healthcare products Regulatory Agency (MHRA) have informed us of of action they have taken today regarding the drug Tacromilus.
It informs healthcare professionals to minimise the risk of medication errors caused by inadvertent switching between brands. Prescribers should prescribe Tacromilus products by brand name only. Pharmacists should always dispense the exact brand prescribed, and should contact the prescriber if the prescription is not clear, to ensure that the appropriate medicine is dispensed.
Switching between different pharmaceutical forms of Tacromilus requires careful medical supervision, and therapeutic monitoring. Patients should be advised to take careful note of the brand name of their usual Tacromilus medicine and should check with their doctor or pharmacist if they receive a different brand, or if they have any questions about their prescription, for example,. about the dose.